Mackenzie Financial
SPRO icon

Mackenzie Financial’s Spero Therapeutics SPRO Stock Holding History

Mackenzie Financial’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-209,031
Closed -$151K – 1792
2025
Q1 		$151K Buy
209,031
+21,472
+11% +$18.1K ﹤0.01% 1554
2024
Q4 		$193K Buy
187,559
+155,656
+488% +$185K ﹤0.01% 1569
2024
Q3 		$42.8K Sell
31,903
-826
-3% -$1.11K ﹤0.01% 1545
2024
Q2 		$42.5K Buy
32,729
+4,287
+15% +$6.47K ﹤0.01% 1500
2024
Q1 		$48.9K Buy
28,442
+6,980
+33% +$10.9K ﹤0.01% 1484
2023
Q4 		$31.5K Buy
21,462
+4,264
+25% +$5.08K ﹤0.01% 1471
2023
Q3 		$20.1K Hold
17,198
– – ﹤0.01% 1452
2023
Q2 		$25.3K Buy
+17,198
New +$29.4K ﹤0.01% 1491

Other funds holding SPRO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return